Drug Discovery
8 articles
Eli Lilly invests in AI startup Absci for new hair loss treatments
Despite 71% of adolescents with severe alopecia achieving successful hair regrowth with its existing drug, Eli Lilly is now betting on an early-stage AI startup for hair loss treatments.
AI Drug Development Surges: In Silico Trials Market Grows Dramatically
Biotech firm Insilico Medicine used artificial intelligence to discover a novel drug candidate for idiopathic pulmonary fibrosis (IPF) and advance it to Phase I clinical trials in under 30 months, acc
Alnylam partners with Inceptive Nucleics for AI-driven RNAi therapeutics
Alnylam Pharmaceuticals, a leader in RNAi therapeutics, just committed $30 million upfront and up to $2 billion to Silicon Valley biotech startup Inceptive Nucleics.
New drug Bepirovirsen functionally cures hepatitis B in some patients
In two late-stage clinical trials, GSK's experimental drug Bepirovirsen achieved a functional cure for 19% of patients with chronic hepatitis B, a disease that has long resisted effective treatment.
New Study Revisits Brain Theory and Neuroscience Concepts
Researchers recently pinpointed that the weight-loss effects of the GLP-1 drug semaglutide hinge on increased levels of a single molecule, cyclic adenosine monophosphate (cAMP), in a specific brain re
UW Medicine AI designs novel miniproteins targeting GPCRs
In one mouse study, a designed miniprotein performed comparably to a clinically used drug with fewer side effects, offering a glimpse into safer treatments for human diseases.
New Quintuple Agonist Targets GLP-1R, GIPR, PPARs in Mice
In mouse models, an experimental obesity and diabetes drug called GLP-1-GIP-Lani not only corrected obesity and diabetes but also significantly outperformed semaglutide in lowering body weight, food i
AI Powers Advances in Drug Discovery and Cancer Detection
A Mayo Clinic-developed AI model can now detect pancreatic cancer on routine CT scans up to three years before a clinical diagnosis.